In addition to tyrosine kinases, I have found that tyrosine phosphatase activity also plays a central role in GPCR mediated suppression of Kv1.2. The tyrosine kinase inhibitors pervanadate or orthovanadate strongly potentiate GPCR mediates suppression of Kv1.2. Further, in some cases, GPCR activation can cause a PKA independent increase in Kv1.2 activity. In collaboration with Bill Tsai, I have found that this increase appears to result from the activation of a receptor tyrosine kinase by a GPCR. This research indicates that GPCR activation results an increase in both tyrosine kinase and tyrosine phosphatase activity. The ultimate effect of GPCR activation on Kv1.2 current may thererfore depend on a dynamic balance between these two opposing signals.
In collaboration
with Teresa Cachero, I have found that tyrosine kinase dependent suppression
of Kv1.2 involves the association of the small guanine nucleotide binding
protein, RhoA with the channel protein's amino terminus. RhoA may
act to suppress Kv1.2 channel activity by virtue of its direct physical
association, by recruiting RhoA activated kinases to the channel, by re-organizing
the actin cytoskeleton in the vicinity of the channel, or by any combination
of these. I am especially interested in the role of the actin cytoskeleton
in Kv1.2 channel activity and suppression since disruption of the actin
cytoskeleton also disrupts both normal channel activity as well as GPCR-mediated
channel suppression. Exploring the role of the cytoskeleton in Kv1.2
channel activity is the focus of my current research efforts.